Clinical trial Recruiting at 1 site Interventional Ages 25 to 45

Autogenic vs. Reciprocal Inhibition Techniques for SI Joint Dysfunction

Official title: Comparative Effects of Autogenic Inhibition and Reciprocal Inhibition Technique on Pain, Functional Disability and Gait in Sacroiliac Joint Dysfuction.

Run by Foundation University Islamabad · NCT07600359 · Data updated 2026-11-12

The study tests two muscle-lengthening techniques (autogenic inhibition and reciprocal inhibition) to see if they reduce pain and improve function and walking in adults with sacroiliac joint dysfunction.

Quick facts

Study typeInterventional
Ages25 Years to 45 Years
SexAll
Enrollment40 (estimated)
SponsorFoundation University Islamabad
Academic / other
Locations1 site (Islamabad, Punjab Province)
StatusRecruiting
StartedMay 15, 2026
Main results expectedJuly 1, 2026
Study endsJuly 15, 2026
Registry record updatedMay 20, 2026
Trial IDNCT07600359 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 25-45 with chronic (>4 weeks) sacroiliac joint-related low back pain and positive SIJ-related tests.

Probably not a fit

Patients with non-specific back pain, hip pathology, neurological issues, or those requiring assistive devices may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study compares two therapy approaches—autogenic inhibition and reciprocal inhibition—delivered over 12 sessions in 3 weeks. Participants have chronic low back pain due to sacroiliac joint dysfunction and will receive either autogenic inhibition of specific hip and back muscles with core stabilization, or reciprocal inhibition of those muscles with standard care. Both groups also receive conventional therapy and core stability exercises, with sessions including TENS and hot packs. Outcomes focus on pain, functional disability, and gait, using predefined clinical tests to confirm eligibility. The trial is conducted at Foundation University Islamabad with a single lead sponsor and no listed collaborators.

Why it matters

Potential benefit: If successful, patients may experience reduced pain and improved mobility and daily functioning.

How similar studies have gone: Previous work has explored similar muscle inhibition approaches, with some evidence of symptom improvement in related musculoskeletal conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients having low back pain greater than 4 weeks
* Patients with positive gaenslen's test, thigh thurst test, standing flexion test, sacral compression and distraction test.
* Patients not having any other condition that can affect gait
* 25-45 years
* Both males and females

Exclusion Criteria:

* Patients having nonspecific low back
* Patients with lumbosacral fusion
* Patients with any neurological condition
* Patients with history of trauma of spine
* Patients with any other lumbar spine condition (lumbar radiculopathy, spinal stenosis, spondylolisthesis, inflammatory arthritis)
* Patients with any hip joint pathology
* Patients using any assistive device

Where it's running

  • Foundation University College of Physical Therapy
    Islamabad, Punjab Province, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.